IN-VITRO ANTIBACTERIAL ACTIVITY of ETHANOLIC EXTRACTS of HEMIDESMUS INDICUS and SIMAROUBA GLAUCA Mamatha A1*, Nidhi Girish2*, Jobi Xavier2 1
Total Page：16
File Type：pdf, Size：1020Kb
Mamatha et al RJLBPCS 2018 www.rjlbpcs.com Life Science Informatics Publications Original Research Article DOI: 10.26479/2018.0406.49 IN-VITRO ANTIBACTERIAL ACTIVITY OF ETHANOLIC EXTRACTS OF HEMIDESMUS INDICUS AND SIMAROUBA GLAUCA Mamatha A1*, Nidhi Girish2*, Jobi Xavier2 1. KLE College of Pharmacy, Bengaluru. 2. Department of Life Sciences, CHRIST (Deemed to be University), Bengaluru. ABSTRACT: One of the biggest issues faced in today’s health-care and medicine is the threat posed by the rapidly emerging drug-resistant microorganisms. Certain Enterobacteriaceae, Pseudomonas aeruginosa, Staphylococcus aureus, etc. are showing resistance against most of the known antibiotics. These organisms being pathogenic need to be contained, and prevented from causing infections. Since the ‘Drugs of last Resort’ are no longer effective, there is an urgent necessity to search for equally effective therapeutics. In the following study, ethanolic extracts of roots of Hemidesmus indicus and leaves of Simarouba glauca were evaluated for their antimicrobial activity against Staphylococcus aureus, Escherichia coli and Bacillus subtilis by well-diffusion method. The minimum inhibitory concentration was determined. Further, the isolation and purification of the constituents responsible are under process. KEYWORDS: Antimicrobials, Herbal treatment, Phytochemicals, Ethanol extracts, Drug-Resistance. Corresponding Author: Dr. Mamatha A* Ph.D. KLE College of Pharmacy, Bengaluru. Email Address: [email protected] 1.INTRODUCTION Sir Alexander Fleming, in the year 1928, discovered Penicillin-G or benzylpenicillin from a fungi Penicillium notatum, which was effective against Staphylococci spp., and many other infection causing bacteria. This penicillin drug belongs to a class known an antimicrobial or specifically antibiotics which are used in the prevention and treatment of bacterial infections. In the 20th century, antibiotics revolutionized medicine and healthcare and was thought to be one of the greatest inventions. However, this invention was not long lived, when bacteria starting evolving mechanisms to ‘resist’ the action of antibiotics. These organisms called ‘Drug resistant bacteria’ are more virulent © 2018 Life Science Informatics Publication All rights reserved Peer review under responsibility of Life Science Informatics Publications 2018 Nov – Dec RJLBPCS 4(6) Page No.639 Mamatha et al RJLBPCS 2018 www.rjlbpcs.com Life Science Informatics Publications and poses greater challenges in the medical community. [1] [2]. Antibacterial agents vary in targets and are classified accordingly. These include inhibition of protein synthesis, inhibition of nucleotide synthesis and blocking certain important metabolic pathways. [3] The antibiotic penicillin was commercially produced by early 1940s and the first case of resistance to this drug was reported in 1965. Since then different classes of antibiotics have been discovered but due to rapid evolution – horizontal gene transfer and mutations, bacteria are becoming ‘multi-drug’ resistant. It is tough to manage such infections especially in immune-compromised patients. Apart from the organism’s natural ability to resist the drug, overuse, inappropriate prescription usage in agriculture and fisheries are the main causes for this scenario. Mechanisms of resistance include - Changes in outer membrane permeability: some small drugs like quinolones diffuse through the porin channels into the bacteria. To acquire resistance some bacteria like Pseudomonas aeruginosa reduce the porins such that the drugs cannot diffuse. Efflux pumps: certain membrane proteins have the ability to expel low-concentration antibiotics as and when they enter the cells. These proteins are called efflux pumps. Macrolides and tetracycline are exported this way conferring resistance to the bacteria. Modification of target molecule: alteration and mutation in target proteins prevent it from being recognized by the antibiotics. Modified Penicillin Binding Proteins (PBP) gives resistance to S. aureus. Mutated DNA gyrase and Topoisomerase provide resistance against Quinolones. Antibiotic inactivation: more advanced strategies of antibiotic resistance includes enzymatic inactivation or degradation. Enzymes like Aminoglycoside-modifying enzymes, β- lactamases and Chloramphenicol-acetyl transferases hydrolyze aminoglycosides, β-lactam antibiotics and chloramphenicol respectively. [2][3][4] Some classical examples resistant bacteria include Vancomycin-resistant Enterococci (VRE), Multidrug-resistant Pseudomonas aeruginosa, Drug-resistant non-typhoid Salmonella, Drug-resistant Shigella, Methicillin-resistant Staphylococcus aureus (MRSA). [2] [4] Drug-resistance along with the ability of bacteria to exist in complex communities called ‘biofilm’ is making treatment, especially for critically-ill patients in intensive care units very challenging [16]. Thus, there is a need for alternate therapeutics to tackle this problem. At this rate of bacterial evolution, newly isolated or synthesized antimicrobial agents might not stay effective for long periods. Hence herbal-based treatments are gaining a lot of importance. [19] [22] Natural products have been used as remedies for various aliments since several centuries [25]. They contain secondary metabolites called phytochemicals present in different parts of the plant – roots, stem, leaves, etc. which have therapeutic properties. Some of these constituents include Alkaloids, Phenols, and Flavonoids, which are known to have anti-bacterial activity [27]. There chemicals, being naturally occurring tend to have fewer side-effects, much lesser toxicity and reportedly similar therapeutic effect as synthetic antibiotics. Hemidesmus indicus commonly called ‘Indian Sarsaparilla’, ‘Nannari’ and ‘Anantmool’ is a small shrub found in South Asia and © 2018 Life Science Informatics Publication All rights reserved Peer review under responsibility of Life Science Informatics Publications 2018 Nov – Dec RJLBPCS 4(6) Page No.640 Mamatha et al RJLBPCS 2018 www.rjlbpcs.com Life Science Informatics Publications extensively in Southern India and Gangetic plains [23]. It belongs to Order Gentianales, Family Ascelepiadaceae, Genus Hemidesmus and Species indicus. Hemidesmus indicus is a short, slender lactiferous shrub. The roots and stem are twined in anticlockwise direction. It is woody and have characteristic, vanillin-like aroma [5]. Leaves are simple, dark green and petiolate. Flowers are small and range from greenish-yellow to purple. This plant possesses Phyto-constituents like glycosides, flavonoids, tannins and sterols [6]. The roots specifically have hemidesmol, resin, glucoside, Coumarins, Terpenoids and Saponin [7]. These shrubs have diverse ethnobotanical properties, some of which include: Antilithic [8], Antivenomous (for Scorpion stings and snake bites) [5], antiulcer, antidiabetic [6], anti-arthritic, antimicrobial [30], anticancer, anti-inflammatory, antileprotic and antioxidant activity [9]. Studies have also reported larvicidal potential of Hemidesmus indicus root extracts [10]. Simarouba glauca also called Bitter wood, Paradise tree and Lakshmi taru [24], belongs to Order Sapindales, Family Simaroubaceae, Genus Simarouba and Species glauca. It has tropic distribution and is found in Africa, America, Madagascar, Cuba, and Brazil and was introduced to India in the later part of 20th century [11]. Simarouba glauca is a medium sized tree and can grow in shade in the canopy of larger trees. The bark is dark and cracked on the outer surface. The leaves are compound, with 3-21 leaflets. These are pinnate, oblong in shape, smooth apex and entire margins. The leaflets are slightly waxy and dark green on the upper surface [11] [12]. The major chemicals present include alkaloids, flavonoids, glycosides, phenolic compounds, saponin, fixed oils and cardinolides [12]. Simarouba glauca has certain biological activities like Anti- amoebic, antibacterial [29], anticancer, anti-malarial, antioxidant, anti-fungal and anti-ulcer [12] [13]. These leaves also have hemolytic and anti-thrombotic activity [14]. The phytochemicals were isolated by cold maceration technique. The powdered plant sample was immersed with a suitable solvent in a stoppered container and allowed to stand for a fixed period of time, at room temperature with occasional stirring, but no violent agitation. [15] [19]. This study, therefore deals with the isolation and evaluation of the antibacterial activity of the extracts against Staphylococcus aureus [31], Bacillus subtilis and Escherichia coli. [21] [26] 2. MATERIALS AND METHODS Collection of Sample Roots of Hemidesmus indicus and leaves of Simarouba glauca were purchased from a local vendor in Bangalore. The samples were authenticated to be root of Hemidesmus indicus and leaves Simarouba glauca by Dr. Mamatha A, Associate Professor, KLE College of Pharmacy, Bengaluru and the voucher specimens were deposited. Pre-extraction procedure The collected samples were then shade dried for about 10 days, tossing every 6 hours. The samples were then pulverized in an electric blender to coarse powder, which was then stored in air tight containers until used. © 2018 Life Science Informatics Publication All rights reserved Peer review under responsibility of Life Science Informatics Publications 2018 Nov – Dec RJLBPCS 4(6) Page No.641 Mamatha et al RJLBPCS 2018 www.rjlbpcs.com Life Science Informatics Publications Extraction Maceration - 10g of the plant powder was soaked in 100ml of distilled water and ethanol separately